Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Drug-related morbidity and mortality and the economic impact of pharmaceutical care.

Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm. 1997;54(5):554-8.

Save
Print
March 6, 2005
Johnson JA, Bootman JL. Am J Health Syst Pharm. 1997;54(5):554-8.
View more articles from the same authors.

Based on a model previously used to estimate health care costs of drug-related problems, this study measured the economic impact of providing pharmaceutical care to an ambulatory patient population. The authors used a probability pathway model and the input of a selected expert panel of pharmacists to determine the effects of pharmaceutical care on cost savings. They concluded that with the reductions in negative therapeutic outcomes, pharmaceutical care can avoid more than $45 billion in direct health care costs. Using this study and their previous research, the authors support the growth of active pharmacy involvement in improving patient care and coordination.

Save
Print
Cite
Citation

Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm. 1997;54(5):554-8.

Related Resources From the Same Author(s)
Related Resources
See More About The Topic